ZES Bioscience Pvt. Ltd. is dedicated to becoming a 'one-stop shop' for our clients. GLP safety evaluation is an essential step in the drug discovery process, providing critical data for our clients to make rapid pipeline choices. ZES Bioscience Pvt. Ltd. provides Safety Assessment and Toxicology Services from its CPCSEA-certified research facility in our sister organization, PBRI, Bhopal, India. In addition to current discovery phase pharmacokinetic and effectiveness data, toxicologists at ZES Bioscience Pvt. Ltd. use data from non-GLP acute and dosage range finding investigations to improve the dosing regimen for GLP repeat-dose toxicity and safety studies. These non-GLP staging studies are critical for determining a test article's hazardous threshold, which will then be used to develop crucial GLP trials. A bioanalytical approach serves as the foundation for evaluating any association between adverse effects and test materials. Our professional bioanalytical team will create, optimize, and verify all bioanalytical techniques for each species and matrix from discovery to development, whether it is an industrial chemical, a medicine, or a plant-extract-based biostimulant.